Our findings corroborate this pattern: on admission, 43.8% of patients had leukocytosis, 56.3% had anaemia, 41.7% showed elevated CRP and 60.0% had raised ESR, whereas conventional tumour markers remained within normal limits. The gene discussed is CRP; the disease is anemia.